Arteris, Inc. has reported a significant share disposal by its President and CEO, Charles Janac. On October 5, 2026, Janac sold 11,452 shares of the company’s common stock. This event is notable as it reflects ongoing executive transactions within the semiconductor industry, where leadership adjustments can impact investor sentiment and company strategy.
Background
Arteris, Inc., incorporated in Delaware, operates in the semiconductor and related devices sector (SIC: 3674). The company trades under the ticker symbol AIP on the Nasdaq exchange. As a smaller reporting company and an emerging growth company, Arteris is subject to specific regulatory requirements. Recent filings include multiple Form 4 submissions on October 6, 2026, indicating active management transactions.
What the Filing Says
The filing, accession number 0001068987-26-000021, details Janac's sale of shares at a weighted average price of $24.2741, with prices ranging from $23.89 to $24.49. The transaction was made under a 10b5-1 trading plan adopted on December 12, 2025. Following this sale, Janac retains ownership of 154,337 shares directly and holds additional shares through Bayview Legacy, LLC and the Charles and Lydia Janac Trust.
Impact
This transaction may affect various stakeholders, including investors and analysts observing executive actions within Arteris and the broader semiconductor industry. As Janac continues to manage significant holdings, his actions may signal confidence or strategic shifts that could resonate throughout the sector.
What's Next
The filing does not say what happens next.